Management of late distant metastases after trimodality therapy for esophageal cancer

Trimodality therapy has been shown in preliminary studies to increase survival in esophageal cancer. Distant recurrence remains the main pattern of failure. A case of aggressive treatment of two metachronous solitary visceral metastases is presented.